EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure

Huijuan Chen, Lingqi Xu

Frontiers in Cardiovascular Medicine · 01.06.2026 · 13

DOI: 10.3389/fcvm.2026.1751022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 01.06.2026. Verfasst von Huijuan Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Hospital of Changsha, Changsha, China. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF) is a major health threat, with aging and programmed cell death (PCD) playing key roles. However, the link between aging-related PCD (aging-PCD) genes and HF remains unclear.

Methods

We used ssGSEA and random forest to analyze PCD types in HF, identified aging-related PCDs via correlation analysis, and applied eight machine learning algorithms to develop a diagnostic model. SHAP and LIME were used to explain key features, and the relationship between the aging-PCD index and immune microenvironment was explored. Gene expression was verified by qRT-PCR, and the function of STEAP3 was further investigated in an H 2 O 2 -induced AC16 cell model. Ferroptosis-related changes were assessed by measuring reactive oxygen species (ROS), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and ferrous ion (Fe 2+ ) levels.

Results

Ferroptosis, autophagy, and necroptosis were strongly correlated with aging in HF. Eighteen differentially expressed aging-related PCD genes were identified. The LASSO model showed the best diagnostic performance. Significant differences in the immune microenvironment were observed between the aging-PCD index-high and index-low groups. A regulatory network of 15 key genes and 19 transcription factors was constructed. The qRT-PCR results validated the bioinformatics analysis. Functional experiments further suggested that STEAP3 may participate in ferroptosis-related injury in cardiomyocytes, potentially through glutathione metabolism (GPX4/SLC7A11 axis) and iron homeostasis.

Conclusion

We identified aging-related PCD signatures in HF that may provide candidate biomarkers for further clinical validation.

Schlagwörter

Stichwörter der Autor:innen

agingheart failuremachine learningprogrammed cell deathsteap3

Autor:innen und Institutionen

  • Department of Cardiology, The First Hospital of Changsha, Changsha, China.
  • School of Medicine, Yueyang Vocational Technical College, Yueyang, China.

Zitieren

APA

Chen, H., & Xu, L. (2026). Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1751022

Vancouver

Chen H, Xu L. Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1751022

BibTeX
@article{Chen2026,
  author = {Chen, Huijuan and Xu, Lingqi},
  title = {Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1751022}
}
Kostenlos starten →